Clinical genetics of amyotrophic lateral sclerosis in Japan: An update

2Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Amyotrophic lateral sclerosis (ALS) is an adult onset neurodegenerative disorder characterized by the death of upper and lower motor neurons. In familial ALS kinders with mutations in the SOD1 gene, the age of onset of weakness varies greatly but the duration of illness appears to be characteristic to each mutation. Mutations in the fused in sarcoma/translated in liposarcoma (FUS/TLS) gene have been discovered to be associated with familial ALS. In a Japanese family with familial ALS, we found the R521C FUS mutation, which has been reported to be found in various ethnic backgrounds. The family history revealed 23 patients with ALS among 46 family members, suggesting a 100% penetrance rate. They developed muscle weakness at an average age of 35.3 years, and the average age of death was 37.2 years. Neuropathological examination revealed remarkable atrophy of the brainstem tegmentum characterized by cytoplasmic basophilic inclusion bodies in the neurons of the brainstem. The frequency of a hexanucleotide repeat expansion in C90RF72 with familial ALS has been estimated as approximately 5% in Japan, although the one Japanese patient was identified as a carrier of the C90RF72 expansion carried the Finnish risk haplotype.

Cite

CITATION STYLE

APA

Aoki, M., Warita, H., Suzuki, N., & Kato, M. (2012). Clinical genetics of amyotrophic lateral sclerosis in Japan: An update. In Clinical Neurology (Vol. 52, pp. 844–847). https://doi.org/10.5692/clinicalneurol.52.844

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free